These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17283273)

  • 1. Letter by Pieroni et al regarding article, "Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy".
    Pieroni M; Bellocci F; Crea F
    Circulation; 2007 Feb; 115(5):e67; author reply e68. PubMed ID: 17283273
    [No Abstract]   [Full Text] [Related]  

  • 2. Images in cardiovascular medicine. Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy.
    Reffelmann T; Naami A; Spuentrup E; Kühl HP
    Circulation; 2006 Aug; 114(8):e357-8. PubMed ID: 16923761
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy.
    Ratliff NB; Estes ML; Myles JL; Shirey EK; McMahon JT
    N Engl J Med; 1987 Jan; 316(4):191-3. PubMed ID: 3796692
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
    Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyopathy: magnetic resonance imaging evaluation.
    Mueller GC; Attili A
    Semin Roentgenol; 2008 Jul; 43(3):204-22. PubMed ID: 18486682
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance in the evaluation of hypertrophic and infiltrative cardiomyopathies.
    O'Hanlon R; Pennell DJ
    Heart Fail Clin; 2009 Jul; 5(3):369-87, vi. PubMed ID: 19564014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease.
    Syed IS; Martinez MW; Feng DL; Glockner JF
    Int J Cardiol; 2008 Jun; 126(3):e50-2. PubMed ID: 17399811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular magnetic resonance assessment of ischemic and nonischemic cardiomyopathies.
    Raney AR; Bello D
    Heart Fail Clin; 2006 Apr; 2(2):145-61. PubMed ID: 17386886
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
    Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
    Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report. Cardiac amyloidosis mimicking Fabry's disease in cardiac magnetic resonance imaging.
    Kirschbaum SW; Baks T; Kofflard MJ; van Geuns RJ
    Clin Radiol; 2008 Nov; 63(11):1274-6. PubMed ID: 18929045
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of vasodilator stress myocardial contrast echocardiography and magnetic resonance imaging for the differential diagnosis of ischemic versus nonischemic cardiomyopathy.
    Mor-Avi V; Koch R; Holper EM; Goonewardena S; Coon PD; Min JK; Fedson S; Ward RP; Lang RM
    J Am Soc Echocardiogr; 2008 May; 21(5):425-32. PubMed ID: 18187290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Images in cardiovascular medicine. No delayed enhancement on contrast magnetic resonance imaging with Takotsubo cardiomyopathy.
    Teraoka K; Kiuchi S; Takada N; Hirano M; Yamashina A
    Circulation; 2005 Apr; 111(16):e261-2. PubMed ID: 15851606
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxychloroquine: a treatable cause of cardiomyopathy.
    Abbasi S; Tarter L; Farzaneh-Far R; Farzaneh-Far A
    J Am Coll Cardiol; 2012 Aug; 60(8):786. PubMed ID: 22898072
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
    Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
    J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience.
    Silva C; Moon JC; Elkington AG; John AS; Mohiaddin RH; Pennell DJ
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1076-9. PubMed ID: 18163027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical form of Tako-Tsubo cardiomyopathy.
    Pujadas S; Punti J; Carreras F; Leta R; Pons-Llado G
    J Cardiovasc Magn Reson; 2007; 9(4):697-9. PubMed ID: 17578726
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging.
    Sato Y; Matsumoto N; Kunimasa T; Matsuo S; Yoda S; Tani S; Kunimoto S; Saito S; Hirayama A
    Int J Cardiol; 2008 Dec; 131(1):e41-3. PubMed ID: 17920709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endomyocardial biopsy in cardiomyopathy: when and why?].
    Schultheiss HP; Kühl U
    Dtsch Med Wochenschr; 2009 Apr; 134(15):769-72. PubMed ID: 19340757
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic endomyocardial biopsy pathology--general biopsy considerations, and its use for myocarditis and cardiomyopathy: a review.
    Veinot JP
    Can J Cardiol; 2002 Jan; 18(1):55-65. PubMed ID: 11826329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac magnetic resonance in myocardial disease.
    Sechtem U; Mahrholdt H; Vogelsberg H
    Heart; 2007 Dec; 93(12):1520-7. PubMed ID: 16757544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.